BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10972909)

  • 1. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice.
    Ulvestad E; Kanestrøm A; Madland TM; Thomassen E; Haga HJ; Vollset SE
    Scand J Immunol; 2000 Sep; 52(3):309-15. PubMed ID: 10972909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics and clinical utility of a hybrid ELISA for detection of ANA.
    Ulvestad E
    APMIS; 2001 Mar; 109(3):217-22. PubMed ID: 11430499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A.
    Pollock W; Toh BH
    J Clin Pathol; 1999 Sep; 52(9):684-7. PubMed ID: 10655991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases].
    Grypiotis P; Ruffatti A; Tonello M; Winzler C; Radu C; Zampieri S; Favaro M; Calligaro A; Todesco S
    Reumatismo; 2002; 54(3):232-7. PubMed ID: 12404031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate.
    Tanaka N; Muro Y; Sugiura K; Tomita Y
    Mod Rheumatol; 2008; 18(6):585-92. PubMed ID: 18633690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and necrosis increase antigenicity of proteins recognized by antinuclear antibodies.
    Herrera-vanOostdam DA; Esparza-Ibarra E; Ramírez-Sandoval R; Ortíz V; Bollain-y-Goitia JJ; Avalos-Diaz E; Herrera-Esparza R
    Reumatismo; 2004; 56(3):156-61. PubMed ID: 15470521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
    Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
    Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
    Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
    Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antinuclear antibodies in systemic autoimmune disease].
    Rösken GHJ; van Beek AA; Bakker-Jonges LE; Schreurs MWJ
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical diagnostic performance of different methods for the detection of antibodies to extractable nuclear antigens in connective tissue diseases: a cohort study.
    Lora PS; Laurino CC; Becker BS; Monticielo OA; Brenol JC; Xavier RM
    Clin Lab; 2011; 57(7-8):625-9. PubMed ID: 21888028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays.
    Emlen W; O'Neill L
    Arthritis Rheum; 1997 Sep; 40(9):1612-8. PubMed ID: 9324015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a multiplex flow immunoassay versus conventional assays in detecting autoantibodies in systemic lupus erythematosus.
    Au EY; Ip WK; Lau CS; Chan YT
    Hong Kong Med J; 2018 Jun; 24(3):261-269. PubMed ID: 29807953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay.
    Jang J; Kim S; Kim HS; Lee KA; Park J; Park Y
    J Int Med Res; 2021 Jun; 49(6):3000605211014390. PubMed ID: 34154430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.
    Haugbro K; Nossent JC; Winkler T; Figenschau Y; Rekvig OP
    Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The optimization of techniques complex of serologic diagnostics of connective tissue systemic diseases].
    Lazareva NM; Lapin SV; Mazing AV; Bulgakova TV; Ilivanova EP; Maslianskiĭ AL; Totolian AA
    Klin Lab Diagn; 2011 Dec; (12):12-7. PubMed ID: 22416425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.